Results 31 to 40 of about 1,910,786 (266)

Test negative designs with uncertainty, sensitivity, and specificity [PDF]

open access: yes, 2021
AbstractTest-negative designs (TNDs) can be used to estimate vaccine effectiveness by comparing the relative rates of the target disease and symptomatically similar diseases among vaccinated and unvaccinated populations. However, the diagnostic tests used to identify the target disease typically suffer from imperfect sensitivity and specificity ...
Erik K. Johnson   +4 more
openaire   +1 more source

Temporal Confounding in the Test-Negative Design

open access: yesAmerican Journal of Epidemiology, 2020
Abstract In the test-negative design, routine testing at health-care facilities is leveraged to estimate the effectiveness of an intervention such as a vaccine. The odds of vaccination for individuals who test positive for a target pathogen is compared with the odds of vaccination for individuals who test negative for that pathogen ...
Natalie E, Dean   +2 more
openaire   +3 more sources

Influenza vaccine effectiveness among children, 2011 – 2021: a test-negative design-based evaluation

open access: yesZhongguo gonggong weisheng, 2022
ObjectiveTo evaluate influenza vaccine effectiveness (VE) in preventing laboratory confirmed influenza illness among children aged 6 – 59 months during 2011 – 2021, and to provide evidences for improving vaccination recommendation and policy-making ...
Li-ping YI, Wan-qing ZHANG, Li-ling CHEN
doaj   +1 more source

Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND) [PDF]

open access: yesClinical Infectious Diseases, 2020
Abstract With rapid and accurate molecular influenza testing now widely available in clinical settings, influenza vaccine effectiveness (VE) studies can prospectively select participants for enrollment based on real-time results rather than enrolling all eligible patients regardless of influenza status, as in the traditional test ...
Leora R Feldstein   +53 more
openaire   +3 more sources

Influenza vaccine effectiveness in primary and secondary school students: an ILI surveillance-based test-negative design case-control study in a district of Shenzhen city during 2021 – 2022 influenza season

open access: yesZhongguo gonggong weisheng, 2023
ObjectiveTo evaluate the vaccine effectiveness (VE) of inactivated trivalent influenza vaccine in primary and secondary school students. MethodsRespiratory specimens were detected with PCR for influenza virus nucleic acid among 286 primary and secondary ...
Shiqiang JIANG   +4 more
doaj   +1 more source

Test-negative Design: Basic Principles, Methods of Implementation, Types of Derivatives, Advantages, Limitations, and Applications [PDF]

open access: yesZhongguo quanke yixue, 2022
As a simple, rapid and effective research method, test-negative design (TND) has been widely used to support the evaluation of post-marketing effectiveness of vaccines and efficacies of interventions in healthcare institutions, showing a magnificent ...
WU Ting, LIU Jue
doaj   +1 more source

A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Since TND could be an appropriate method to assess vaccine effectiveness, we want to know whether it may be used for the estimation of vaccine immunological surrogate endpoints, like case-control study.
Li Zhang   +5 more
doaj   +1 more source

Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform

open access: yesFrontiers in Public Health, 2023
IntroductionDevelopment of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public–private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public ...
Anke L. Stuurman   +119 more
doaj   +1 more source

Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae. Microorganisms 2022, 10, 560

open access: yesMicroorganisms, 2022
The 23-valent pneumococcal polysaccharide vaccine (PPSV23) targets 23 common serotypes and is recommended for use in adults in various countries to protect against pneumococcal infection.
Nicole Cossrow   +3 more
doaj   +1 more source

Evaluating Real-World COVID-19 Vaccine Effectiveness Using a Test-Negative Case-Control Design [PDF]

open access: yesJournal of Comparative Effectiveness Research, 2022
AbstractIt is important to assess the extent to which the real-world effectiveness of marketed vaccines is consistent with that observed in the clinical trials, and to characterize how well vaccines prevent COVID-19 symptoms. We conducted a modified test-negative design (TND) to evaluate the RW effectiveness of three COVID-19 vaccines by leveraging ...
Matthew W Reynolds   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy